Science Explorer Back to mapMap
Discussion
Researcher · Aarhus University Hospital · Denmark

Grete Fossum Lauritzsen

Grete Fossum Lauritzsen publishes mostly in Pathology and Forensic Medicine, Oncology and Immunology, on topics such as Lymphoma Diagnosis and Treatment, CAR-T cell therapy research and T-cell and Retrovirus Studies.

OpenAlex
World rank
#1,542,860
of 7,710,434 ranked researchers
Rank in Denmark
#11,667
of 43,819
Works
68
Citations
3.4k
Citations per work
50.3
h-index
24
i10-index 35Top 20% in Pathology and Forensic Medicine
Grete Fossum Lauritzsen

What does Grete Fossum Lauritzsen research?

Grete Fossum Lauritzsen's work is mostly in Medicine (64%), Immunology and Microbiology (22%).

Health Sciences: 44 works · 64.2% of their workMedicine: 44 works · 64.2% of their workPathology and Forensic Medicine: 19 works · 28.5% of their workOncology: 15 works · 22.3% of their workGenetics: 3 works · 5.0% of their workPulmonary and Respiratory Medicine: 3 works · 5.0% of their workNeurology: 2 works · 3.4% of their workLife Sciences: 15 works · 21.8% of their workImmunology and Microbiology: 15 works · 21.8% of their workImmunology: 15 works · 21.8% of their workEverything else: 10 works · 14.0% of their workTHEIR WORKGrete FossumLauritzsen68works
Life Sciences22%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4464.2%
    1. Immunology and Microbiology1521.8%
  3. Everything else1014.0%
  1. 1Pathology and Forensic Medicine28% of their works
  2. 2Oncology22% of their works
  3. 3Immunology22% of their works
  4. 4Genetics5% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Neurology3% of their works

Research topics

Which keywords describe Grete Fossum Lauritzsen's research?

The keywords of their largest research topics: Lymphoma, Rituximab, Classification, Molecular Profiling, Immunotherapy, Leukemia, Cancer Immunotherapy and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Lymphoma863 topics
  2. Rituximab592 topics
  3. Classification501 topic
  4. Molecular Profiling501 topic
  5. Immunotherapy362 topics
  6. Leukemia362 topics
  7. Cancer Immunotherapy272 topics
  8. CAR T Cells201 topic
  9. Chimeric Antigen Receptor201 topic
  10. HTLV-1161 topic
  11. Infection161 topic
  12. Epstein-Barr Virus121 topic
  13. Kaposi's Sarcoma121 topic
  14. Chronic Lymphocytic Leukemia91 topic
  15. Genomic Aberrations91 topic
  16. NK Cell Recognition81 topic
  17. Natural Killer Cells81 topic
  18. Dendritic Cells71 topic
  19. Foxp371 topic
  20. Immunity71 topic
  21. TGF-ß71 topic

Where does Grete Fossum Lauritzsen work?

Grete Fossum Lauritzsen's main affiliation in the publication record is Aarhus University Hospital, Denmark.

How many publications and citations does Grete Fossum Lauritzsen have?

OpenAlex counts 68 works and 3,417 citations for Grete Fossum Lauritzsen, an h-index of 24, ranking #1,542,860 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Grete Fossum Lauritzsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.